Profile data is unavailable for this security.
Mergers & acquisitions
| Acquired company | 4519:TYO since announced | Transaction value |
|---|---|---|
| Renalys Pharma Inc | 28.18% | 203.17m |
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.
0.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Associates, Inc. (IM)as of 31 Jan 2026 | 1.24m | 0.04% |
| Strategic Advisers LLCas of 31 Dec 2025 | 959.20k | 0.03% |
| Confluence Investment Management LLCas of 31 Dec 2025 | 45.37k | 0.00% |
| RhumbLine Advisers LPas of 31 Dec 2025 | 44.38k | 0.00% |
| Sterling Capital Management LLCas of 31 Dec 2025 | 44.02k | 0.00% |
| Causeway Capital Management LLCas of 05 Feb 2026 | 34.81k | 0.00% |
| GAMMA Investing LLCas of 31 Dec 2025 | 12.65k | 0.00% |
| PNC Wealth Management LLCas of 31 Dec 2025 | 10.55k | 0.00% |
| BlackRock Advisors LLCas of 05 Feb 2026 | 8.45k | 0.00% |
| ShariaPortfolio, Inc.as of 05 Feb 2026 | 8.12k | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
